EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Pathogenic aspects of fructose consumption in metabolic dysfunction-associated steatotic liver disease (MASLD): A narrative review

Katharina Burger, Michael Michael Trauner, Ina Bergheim

Cell Stress · 24.06.2025 · 9 · 49-64

DOI: 10.15698/cst2025.06.305 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Stress, online erschienen am 24.06.2025. Verfasst von Katharina Burger und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutritional Sciences, Molecular Nutritional Science, University of Vienna, Vienna, Austria. Die Arbeit wurde bisher 12-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly referred to non-alcoholic fatty liver disease (NAFLD), has become a global health concern with a still increasing prevalence. One of the major contributing factors to its pathogenesis is overnutrition. In recent years, a discussion has been started that not only general overnutrition but also specific dietary patterns like the so-called ‘Western diet’ composed of foods rich in saturated fats, cholesterol, and sugar (especially fructose) but low in fiber and polyunsaturated fats, may contribute to the development of MASLD. Evidence from human (intervention) studies regarding the effects of sugar and especially fructose intake is limited and contradictory with respect to the development of MASLD. Still, some scientific liver societies have incorporated a reduction of sugar-sweetened beverages (SSBs) being rich in fructose in their life-style advice for the treatment of MASLD. Being metabolized independently of insulin, fructose has been proposed to be processed more rapidly than glucose, leading to increased lipogenesis and subsequently to hepatic lipid accumulation. Results of more recent experimental studies suggest that an elevated intake of fructose may also affect gut microbiota composition, alter small intestinal morphology and impair intestinal barrier function subsequently leading to an increased translocation of pathogen-associated molecular patterns (PAMPs) into the portal circulation. In this narrative review we summarize recent findings related to the relationship of fructose intake and MASLD, herein focusing on the gut-liver axis and the discrepancy between studies in humans and model organisms.

Schlagwörter

Stichwörter der Autor:innen

PAMPsgut-liver axisintestinal barriermicrobiomesteatotic liver diseasesugar

Autor:innen und Institutionen

  • Department of Nutritional Sciences, Molecular Nutritional Science, University of Vienna, Vienna, Austria.
  • Division of Gastroenterology & Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.

Zitieren

APA

Burger, K., Michael Trauner, M., & Bergheim, I. (2025). Pathogenic aspects of fructose consumption in metabolic dysfunction-associated steatotic liver disease (MASLD): A narrative review. Cell Stress, 9, 49-64. https://doi.org/10.15698/cst2025.06.305

Vancouver

Burger K, Michael Trauner M, Bergheim I. Pathogenic aspects of fructose consumption in metabolic dysfunction-associated steatotic liver disease (MASLD): A narrative review. Cell Stress. 2025;9:49-64. doi:10.15698/cst2025.06.305

BibTeX
@article{Burger2025,
  author = {Burger, Katharina and Michael Trauner, Michael and Bergheim, Ina},
  title = {Pathogenic aspects of fructose consumption in metabolic dysfunction-associated steatotic liver disease (MASLD): A narrative review},
  journal = {Cell Stress},
  year = {2025},
  volume = {9},
  pages = {49--64},
  doi = {10.15698/cst2025.06.305}
}
Kostenlos starten →